Remove agencies committee-on-foreign-investment-in-the-united-states articles
article thumbnail

Why Sovereign Debt Speculation Should Be Regulated in the United States

Reynolds Holding

In a recent article, I argue for U.S. A bill introduced in the New York State Legislature last legislative session could have significantly reduced speculation by modifying the champerty rule but was also not passed. [4] 5] Thus, in cases brought by vulture funds, states lose the immunity privilege associated with sovereign debt.

Finance 59
article thumbnail

Goodwin Procter Discusses Yet Another Two Decisions in Bernie Madoff Case

Reynolds Holding

Madoff Investment Securities LLC (BLMIS) was a Ponzi scheme led to its liquidation under the Securities Investor Protection Act (SIPA). 1 A SIPA liquidation is designed to collect “customer property” for ratable distribution among customers based on their “net equity” — investments minus withdrawals (i.e., loss of principal).

Banking 40
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

M&A Pre-Flight Check: Avoiding Common Issues in Aerospace & Defense Acquisitions

Shephard Mullin M&A

But much like the machines they produce, acquiring an A&D company is complex and requires significant investment of both time and money to be done properly. As anyone who follows the industry can tell you, mergers and acquisitions activity in the aerospace and defense industry has remained robust over the past decade.

article thumbnail

SEC Chair Testifies Before U.S. Senate Committee on Banking, Housing, and Urban Affairs

Reynolds Holding

Good morning, Chairman Brown, Ranking Member Scott, and members of the Committee. At this remarkable agency, we serve investors building for a better future and issuers raising money to fund innovation, while overseeing the $100 trillion capital markets where they meet. I am proud of this agency. The core principles of U.S.

Banking 40
article thumbnail

Cooley’s 2019 Life Sciences M&A Year in Review

Cooley M&A

A wave of big-ticket transactions by global pharmaceutical companies drove life sciences M&A activity to its fourth-largest year on record in 2019, with aggregate deal value in the pharmaceutical, medical and biotech industry reaching $234.2 Year of the Life Sciences Mega-Deals. billion acquisition of The Medicines Company.

article thumbnail

Cooley’s 2023 Cross-Border M&A Year in Review: Navigating Choppy Waters into a More Buoyant 2024

Cooley M&A

Cross-border M&A activity in 2023 was impacted by heightened geopolitical conflicts, high inflation and interest rates, and increased regulatory pressures as the global economy remained clouded by looming recession fears. Deal financing became more difficult and expensive, placing more emphasis on alternative funding and value creation.

article thumbnail

ESG Regulations Guide: Decoding the US, UK, and EU Climate Rules

Audit Board

They look at you like you’re an expert, but you don’t always feel like one. With the rise of each new question or headline about environmental, social, and governance (ESG) risks and regulatory requirements, your organization expects you to have answers. Companies should be working to understand the cross-border implications for their operations.